Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
BTG plc was a global specialist healthcare company focused on developing and commercializing innovative products in interventional medicine. Their portfolio targeted critical care, cancer, and vascular diseases, aiming to provide minimally-invasive therapies that improved patient outcomes. Key areas included interventional oncology (e.g., TheraSphere™ Y-90 glass microspheres, GALIL™ cryoablation system), interventional vascular (e.g., EKOS™ Endovascular System), and a specialty pharmaceuticals business (e.g., DigiFab®, Voraxaze®). In August 2019, BTG was acquired by Boston Scientific for $4.2 billion, integrating its innovative products and pipeline into Boston Scientific's Interventional Oncology and Peripheral Interventions businesses, enhancing their offerings in these critical care areas.
Served as the central hub for global operations, strategic decision-making, corporate governance, R&D oversight, and administrative functions for BTG plc prior to its acquisition.
Situated in Fleet Place, a modern commercial development in central London, the headquarters offered contemporary office facilities, excellent connectivity via nearby transport hubs (City Thameslink, Blackfriars), and proximity to London's financial and business ecosystem.
BTG was recognized for fostering a culture centered on scientific innovation, collaboration across specialized teams, and a strong commitment to improving patient lives through advanced medical technologies. The London HQ likely embodied this with a professional, dynamic, and results-oriented environment.
The London headquarters was pivotal in managing BTG's international growth, its listing on the London Stock Exchange, R&D pipeline development, and global commercialization strategies for its specialized medical products.
Prior to its acquisition by Boston Scientific, BTG plc had a significant global presence. Its commercial operations extended across North America, Europe, and Asia Pacific, with products sold in over 100 countries. Key functions supported globally included direct sales and marketing teams in major markets, a network of distribution partners in other regions, clinical research and development operations, regulatory affairs, manufacturing oversight, and medical education for its interventional medicine and specialty pharmaceutical portfolios.
5 Fleet Place
London
N/A
United Kingdom
Address: Formerly: Five Tower Bridge, 300 Barr Harbor Dr, Suite 500, West Conshohocken, PA 19428 (Operations now integrated with Boston Scientific)
This location was critical for driving BTG's growth in the largest healthcare market in the world, managing U.S. product launches, supporting clinical trials, and engaging with key opinion leaders and healthcare providers across the United States.
Address: Formerly associated with Nordion's medical isotopes business acquired by BTG (Operations now integrated with Boston Scientific). Specific past BTG address details may vary.
Supported specific aspects of BTG's specialty pharmaceuticals and radiopharmaceutical supply chain and development in North America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BTG Group' leadership includes:
BTG Group has been backed by several prominent investors over the years, including:
BTG plc was acquired by Boston Scientific in August 2019 and is no longer an independent operating entity. Consequently, there have been no executive hires or exits specifically for 'BTG' as a standalone company in the last 12 months. Key executives transitioned at the time of the acquisition or subsequently moved to new roles outside of the integrated BTG operations within Boston Scientific.
Discover the tools BTG Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition in 2019, BTG plc likely used common corporate email formats for its domain btgplc.com. Common patterns included first initial followed by last name, or first name separated from last name by a period.
[first_initial][last]@btgplc.com or [first].[last]@btgplc.com
Format
jdoe@btgplc.com or jane.doe@btgplc.com
Example
75%
Success rate
Boston Scientific Newsroom • April 17, 2023
Boston Scientific shared positive results from the Dosisphere-001 study at the European Conference on Interventional Oncology (ECIO) 2023, demonstrating the efficacy of personalized dosimetry with TheraSphere™ Y-90 Glass Microspheres (a legacy BTG product) in treating hepatocellular carcinoma (HCC). The data supports TheraSphere's role in improving outcomes for liver cancer patients....more
Boston Scientific Newsroom • February 22, 2023
Boston Scientific announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications for the EKOS™ Endovascular System (a legacy BTG product) to treat pulmonary embolism. This highlights ongoing development and regulatory milestones for key technologies acquired from BTG....more
Boston Scientific Newsroom • August 19, 2019
Boston Scientific announced the completion of its acquisition of BTG plc, a company developing and commercializing products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals. The acquisition was valued at approximately $4.2 billion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BTG Group, are just a search away.